Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
AdvaMed 2015: The MedTech Conference, the leading gathering of medical technology professionals in North America, has issued a call for transformative companies to apply for the MedTech Innovator competition by the May 15 deadline. Learn more